Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved ...

Goldman’s profit roughly doubled in Q4 thanks in large part to surging revenues from deal-making, underwriting, and trading.

Goldman Sachs shares gained in premarket trading Wednesday after the bank reported better-than-expected fourth-quarter ...

Goldman Sachs Group outperformed expectations in its fourth-quarter and full-year earnings with a robust financial showing ...

Goldman Sachs (NYSE: GS) shares traded higher after reporting strong Q4 and full-year 2024 results. Revenue, EPS, and stock ...

Goldman Sachs reported on Wednesday higher fourth-quarter profit above market estimates, powered by strong growth in revenues ...

JPMorgan Chase, Goldman Sachs, Citi and Wells Fargo all reported fourth-quarter earnings Wednesday, and each banking behemoth ...

Goldman Sachs reported blowout earnings for Q4, soundly beating estimates. The gains were fueled by an increase in investment banking fees. Goldman Sachs got a sizable price target upgrade from an ...

Goldman Sachs said its profit more than doubled in the fourth quarter, boosted by companies’ growing appetite for dealmaking.

Goldman Sachs BDC's portfolio has diversified sector exposure, with notable changes in exposure since last coverage. Read why ...

Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...

Goldman Sachs' Q4 2024 earnings per share (EPS) soared to $11.95, significantly surpassing the expected $8.21. Revenue in Q4 hit $13.87 billion, exceeding estimates of $12.36 billion. Fourth ...